Literature DB >> 22451085

[Does the duration of confinement of criminally responsible mentally disordered offenders (§ 21/2 StGB) play a role in the development of a functional psychosyndrome? - A pupillometric investigation].

Josef Grünberger1, Thomas Wisnecky, Katinka Keckeis, Sonja Kaplan, Jutta Heilmann, Patricia Twardowsky, Hans Stöhr, Anna Bösch.   

Abstract

BACKGROUND: Pupillometry is a non-invasive investigation based on the concept that pupillary reagibility depends on a number of specific sensory, mental and emotional variables. By means of the receptor test based on the topical application of the cholinergic antagonist tropicamide cognitive deficits can be evaluated. The present study focuses on the question whether the receptor test is able to differentiate criminally responsible mentally disordered offenders (§ 21/2 StGB) with different durations of confinement concerning the presence of a functional psychosyndrome, as defined by Grünberger.
METHODS: Four groups of offenders with different durations of confinement (group A: confinement 0-2 years, n = 26, X = 33; group B: 2-5 years, n = 29, X = 34; group C: 5-10 years, n = 6, X = 36; group D: >10 years, n = 10, X = 43) were investigated by means of a computer-assisted TV pupillometer. After a baseline measurement 0.01% tropicamide was instilled into the eye. The second measurement was conducted 20 min after the first, the 3rd and 4th measurements in intervals of 20 min.
RESULTS: The groups with a longer duration of confinement showed a reduced activation and vigilance and increased fatigability as compared with the groups of shorter confinement. In the receptor test the group that had been imprisoned for 0-2 years showed more cognitive deficits than those imprisoned for ≥5 years.
CONCLUSIONS: Evaluation of activation, fatigability and vigilance indicates that the duration of confinement plays a role in the development of a functional psychosyndrome. The results of the receptor test, in which the group with a longer duration of confinement showed less pronounced cognitive deficits and no significant changes of the tropicamide effect over time, suggest that in this group a dose change might be required to make the cognitive deficits evident.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22451085     DOI: 10.1007/s10354-012-0063-6

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  7 in total

1.  Pupil assay and Alzheimer's disease: a critical analysis.

Authors:  L F Scinto; D M Rentz; H Potter; K R Daffner
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

2.  [Quantitative personality analysis of first offence and recidivist hardened convicts].

Authors:  H Hoff; J Grünberger; W Sluga; V Scheiber
Journal:  Wien Z Nervenheilkd Grenzgeb       Date:  1970

3.  [Clinical and psychological study of problem prisoners].

Authors:  J Grünberger; W Sluga
Journal:  Wien Z Nervenheilkd Grenzgeb       Date:  1968

4.  [Chronic alcoholism: relation between brain performance and liver damage].

Authors:  J Grünberger; K Irsigler; K Krypsin-Exner
Journal:  Wien Z Nervenheilkd Grenzgeb       Date:  1970

5.  ["Functional psychosyndrome" in deprivation of freedom. Clinical-psychological studies in convicts].

Authors:  J Grünberger; W Sluga
Journal:  Wien Med Wochenschr       Date:  1968-11-09

6.  [The videocorder as a therapeutic aid. A behavior therapeutic technic in convicts].

Authors:  P Berner; J Grünberger; W Sluga
Journal:  Z Psychother Med Psychol       Date:  1971-01

7.  [The pupillary response test as a method to differentiate various types of dementia].

Authors:  Josef Grünberger; Wolfgang Prause; Patrick Frottier; Hans Stöhr; Bernd Saletu; Manfred Haushofer; Michael Rainer
Journal:  Neuropsychiatr       Date:  2009
  7 in total
  1 in total

1.  [Can psychopathy be detected psychophysiologically?].

Authors:  Josef Grünberger; Jutta Heilmann; Thomas Wisnecky; Katinka Keckeis; Daniel Prattinger; Karl-Heinz Ronovsky; Michael Grünberger; Anna Bösch; Hans Stöhr
Journal:  Wien Med Wochenschr       Date:  2015-08-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.